WELL Health Technologies Corp.
WHTCF
$3.42
$0.05351.59%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.03% | 12.72% | 13.84% | 31.94% | 36.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.03% | 12.72% | 13.84% | 31.94% | 36.44% |
| Cost of Revenue | 27.89% | 29.92% | 35.78% | 51.46% | 62.77% |
| Gross Profit | 9.61% | -7.63% | -9.94% | 12.51% | 12.34% |
| SG&A Expenses | 14.18% | 5.84% | 6.90% | 17.70% | 21.98% |
| Depreciation & Amortization | 22.55% | 16.08% | 17.09% | 16.16% | 15.44% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.81% | 20.19% | 23.46% | 35.38% | 42.13% |
| Operating Income | -103.82% | -184.03% | -192.38% | -27.77% | -51.00% |
| Income Before Tax | -201.51% | -259.98% | -171.11% | 2,060.92% | 1,111.41% |
| Income Tax Expenses | -58.92% | -10,966.23% | -1,009.92% | -329.98% | -628.84% |
| Earnings from Continuing Operations | -187.37% | -200.13% | -24.31% | 1,486.60% | 1,374.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 125.80% | 141.03% | 148.48% | -31.91% | 3.14% |
| Net Income | -193.70% | -236.82% | 11,252.40% | 933.27% | 3,285.98% |
| EBIT | -103.82% | -184.03% | -192.38% | -27.77% | -51.00% |
| EBITDA | -14.11% | -61.71% | -72.34% | -4.13% | -15.59% |
| EPS Basic | -193.30% | -233.86% | 2,348.15% | 970.70% | 3,296.03% |
| Normalized Basic EPS | -43.09% | -133.52% | -197.40% | -135.49% | -133.25% |
| EPS Diluted | -198.48% | -270.44% | 725.00% | 788.28% | 2,461.08% |
| Normalized Diluted EPS | -46.61% | -135.27% | -193.77% | -129.58% | -127.84% |
| Average Basic Shares Outstanding | 0.88% | 1.26% | 1.66% | 4.61% | 4.73% |
| Average Diluted Shares Outstanding | -0.64% | 1.14% | 3.68% | 6.65% | 6.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |